Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(565/week)
Manufacturing
(380/week)
Energy
(296/week)
Technology
(386/week)
Environment
(222/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
CStone Pharmaceuticals
Aug 22, 2019
CStone completes registration filing for the Phase I trial of CDK4/6 inhibitor CS3002 in Australia and will soon initiate the study
Aug 19, 2019
Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress
Aug 15, 2019
CStone Pharmaceuticals Reports First Half 2019 Financial Results
Aug 13, 2019
CStone announces first patient dosed in China with BLU-667 for the global Phase I registrational study
Aug 07, 2019
CStone to Build Global R&D Headquarters and Industrialization Base in the Suzhou Industrial Park
Jul 22, 2019
CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML
Jul 09, 2019
CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST
Jun 09, 2019
CStone and Bayer announce global collaboration to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib
Jun 05, 2019
CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in combination therapy for HCC
Jun 03, 2019
Blueprint Medicines' Highly Selective RET Inhibitor BLU-667 Shows Durable Anti-Tumor Activity in Patients with RET-Altered Cancers in Updated ARROW Trial Data Presented at ASCO 2019
Jun 02, 2019
CStone submits new drug application for TIBSOVO(R) in Taiwan for the treatment of relapsed/refractory AML
May 23, 2019
Cstone partner Agios Announces the Phase 3 ClarIDHy Trial of TIBSOVO (ivosidenib) Achieved its Primary Endpoint
May 01, 2019
CStone and Numab announce exclusive regional licensing agreement for ND021, a multi-functional drug candidate and potential next-generation immunotherapy
Apr 16, 2019
First patient dosed in Phase III GEMSTONE-303 study for CS1001 in combination with chemotherapy in first-line gastric adenocarcinoma and gastro-esophageal junction adenocarcinoma
Apr 15, 2019
CStone received IND approval in China for avapritinib Phase I/II bridging registrational study in patients with advanced gastrointestinal stromal tumors
Apr 04, 2019
CStone Pharmaceuticals presented poster of pre-clinical result for CS1003 at AACR
Mar 25, 2019
CStone appoints three distinguished oncology leaders Drs. Paul A. Bunn, Jr., Elizabeth M. Jaffee and Richard S. Finn to its Scientific Advisory Board
Mar 21, 2019
CStone receives approval in China to initiate Phase 1 clinical trial for RET inhibitor BLU-667 (CS3009)
Mar 12, 2019
CStone received IND approval in China for HDAC6 inhibitor CS3003
Feb 26, 2019
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today
‹‹
Page 2
››
Latest News
Apr 24, 2024
Sibelco to enter North American glass recycling industry with acquisition of Strategic Materials, Inc.
Apr 24, 2024
Applied Intuition and Luminar Partner to Accelerate ADAS and AD Development for Automakers
Apr 24, 2024
UP GARAGE USA Co., Ltd.. Will Host Its Grand Opening on April 27 at Garden Grove, California
Apr 24, 2024
Inszone Insurance Services Broadens Niche Expertise with Strategic Acquisition of Van Oppen & Co. 2
Apr 24, 2024
Forbes Names Avangrid Among America’s Best Employers for Diversity
Apr 24, 2024
Earthquakes Announce Udemy as Official Learning and Skills Partner and Official Training Jersey Partner
Apr 24, 2024
Utility Concierge Rebrands as Move Concierge
Apr 24, 2024
US Pole Appoints Scott Smith Northeast Regional Manager
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events